Healthcare -
Biotechnology - NASDAQ - US
$ 0.7099
2.16 %
$ 31.2 M
Market Cap
-0.46
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
24.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Xilio Therapeutics, Inc.
XLO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart XLO
EBIT FORECAST
EBIT Forecast Chart XLO
NET INCOME FORECAST
Net Income Chart XLO